Skip to main content
Skip to main navigation menu
Skip to site footer
Annals of Gastroenterology
Home
About
Current
Early view
Archives
Society
Editorial board
Reviewers
Contact
Submissions
Journal Metrics
Most cited articles
Search
Search
Register
Login
Home
/
Archives
/
Volume 38, No 4 (2025)
Volume 38, No 4 (2025)
Published:
2025-08-04
Table of contents
Review Articles
Endoscopic treatment modalities for the management of gastroparesis: a critical review
Dimitrios I. Ziogas, Anastassios C. Manolakis, Konstantinos Argyriou, Ioannis S. Papanikolaou, Elias Grivas, Andreas Kapsoritakis
353
PDF
HTML
Early-onset colorectal cancer in patients younger than 50 years: a systematic review of the literature
Ilektra D. Kyrochristou, Georgios D. Lianos, Gerasimia D. Kyrochristou, Vaia Georvasili, Vasileios Tatsis, Michail Mitsis, Dimitrios Schizas, Konstantinos Vlachos
364
PDF
HTML
Understanding clinically significant portal hypertension: an in-depth look at pathogenesis, diagnosis and treatment
Emma Vanderschueren, Schalk van der Merwe, Wim Laleman
380
PDF
HTML
Original Articles
Characteristics of early- versus late-onset esophageal adenocarcinoma: insights from the National Inpatient Sample 2016-2020
Sana Rabeeah, Ahmad Mahdi, Vikash Kumar, Jayalekshmi Jayakumar, Bisher Sawaf, Shahem Abbarh, Ali Wakil, Hasan Al-Obaidi, Ahmed El Rahye, Muhammed Elhadi, Yaseen Alastal
392
PDF
HTML
Exploring the competencies of inflammatory bowel disease nurses in Italy: a cross-sectional survey
Elisa Schiavoni, Daniela Greco, Franco Scaldaferri, Daniele Napolitano
401
PDF
HTML
Oral vancomycin is associated with less therapy intensification in adults with symptomatic inflammatory bowel disease and underlying primary sclerosing cholangitis
Chiraag Kulkarni, Abhishek Dimopoulos-Verma, George Triadafilopoulos, Sidhartha R. Sinha
409
PDF
HTML
Office-based flexible sigmoidoscopy allows rapid assessment and management of suspected immune checkpoint inhibitor-related colitis
Alana Siev, Pamela Livingstone, Erika Tom, Tara Corso, Isabel Preeshagul, Michael Postow, Neil J. Shah, Rachel Niec, Mark Schattner, David M. Faleck
415
PDF
HTML
Patterns of prescription and discontinuation of glucagon-like peptide-1 receptor agonists among patients with irritable bowel syndrome
Misha Gautam, Utkarsh Goel, Abbas Bader, Samiya Azim, Noor Hassan, Esmat Sadeddin, Wendell Clarkston, Hassan Ghoz
420
PDF
HTML
Trends and disparities of diverticular disease mortality in the United States before and during the COVID-19 era: estimates from the Centers for Disease Control WONDER database
Thai Hau Koo, Venkata Sunkesula, Rishi Chowdhary, Xue Bin Leong, Ronnie Fass, Ala A. Abdel Jalil
428
PDF
HTML
Increased capture of post-endoscopic retrograde cholangiopancreatography adverse events by delayed (day 7) follow-up calls: a prospective comparison of physician- and nurse-initiated calls
Monique T. Barakat, Subhas Banerjee
440
PDF
HTML
Patients with cystic fibrosis do not have an increased risk of adverse events after endoscopic retrograde cholangiopancreatography: a propensity-matched analysis
Mahmoud Y. Madi, Saqr Alsakarneh, Yassine Kilani, Ryan Plunkett, Razan Aburumman, Farah Heis, Christopher Nguyen, Christine Hachem, Wissam Kiwan
446
PDF
HTML
Neoadjuvant therapy versus upfront surgery approach in resectable pancreatic cancer: a systematic review and meta-analysis
Caroline Tanadi, Kevin Tandarto, Maureen Miracle Stella, Randy Adiwinata, Jeffry Beta Tenggara, Paulus Simadibrata, Marcellus Simadibrata
453
PDF
HTML
Letter to the Editor
Replication and extension of a meta-analysis of antidepressants for irritable bowel syndrome: a comparison of odds ratios and risk ratios using artificial intelligence-powered tools
Lefteris Teperikidis, Christos Mademlis, Georgios hatzinakos, Nikolaos Lazaridis
462
PDF
HTML
Authors’ reply
Maria José Temido, Margarida Cristiano, Carolina Gouveia, Bárbara Mesquita, Pedro Figueiredo, Francisco Portela
463
PDF
HTML
Information
For Readers
For Authors